Laboratorio Farmaceutico Erfo SpA is an Italy-based pharmaceutical company primarily engaged in the nutraceutical sector. The Company specializes in the production of nutritional supplements, that thanks to research and development carried out internally and in collaboration with the University Campus Bio-Medico of Rome and the University of Messina provides products with a scientific value in different therapeutic areas. The Company operates globally.

Employees

Sector

Pharmaceuticals

More about the company

Quotes

Date	Price	Change	Volume
26-09-23	€1.085	-0.46%	10,000
26-09-22	€1.090	0.00%	14,000
26-09-21	€1.090	-0.46%	16,000
26-09-18	€1.095	+0.46%	2,000
26-09-17	€1.090	-1.36%	5,000

Real-time Borsa Italiana

More quotes

Annual profits - Rate of surprise

Company calendar

Market Closed - Borsa Italiana 11:45:00 2026-09-23 EDT			5-day change	1st Jan Change
1.085 ^EUR	-0.46%		-1.81%	-26.19%

08-31	Milan in the pink at the open, oil stocks lead the MIB	AN
08-31	Futures weak; Brent higher after US-Iran attacks	AN

Market Cap	9.29M 10.58M 8.73M 7.98M 14.91M 1.01B 15.02M 105M 40.65M 517M 39.73M 38.86M 1.68B	P/E 2024	30.8x	P/E 2025	17x
Enterprise Value	9.58M 10.92M 9.01M 8.24M 15.39M 1.05B 15.5M 108M 41.94M 533M 41M 40.1M 1.73B	EV / Sales 2024	1.79x	EV / Sales 2025	1.32x
Free-Float	33.31%	Yield 2024 *	-	Yield 2025	-

Markets		Quality
Borsa Italiana	ERFO	Real-time
Deutsche Boerse AG	RK7	Delayed

08-31	Milan in the pink at the open, oil stocks lead the MIB	AN
08-31	Futures weak; Brent higher after US-Iran attacks	AN
08-28	Buying across Europe, Lottomatica goes all-in on the MIB	AN
08-28	Europe pushes higher at the halfway mark, MIB at 52,700	AN
08-27	Laboratorio Farmaceutico Erfo closes half-year with revenue up 2%	AN
08-27	Milan opens lower; STM jumps after Nvidia earnings	AN
08-26	Piazza Affari ends higher, Buzzi leads the MIB	AN
07-06	Laboratorio Erfo continues buyback, acquires 15,000 treasury shares	AN
06-29	Laboratorio Farmaceutico Erfo buys back 14,000 treasury shares	AN
06-22	Erfo Keeps Buying Back Stock, Repurchases 28,000 Shares	AN
06-19	Laboratorio Farmaceutico Erfo S.p.A.'s Equity Buyback announced on December 18, 2024, has expired.	CI
06-15	Laboratorio Farmaceutico Erfo acquires 15,000 treasury shares	AN
06-04	Equities trend higher; banks lead gains on the MIB	AN

Laboratorio Farmaceutico Erfo S.p.A. Stock

Stocks

ERFO

IT0005497885

Pharmaceuticals

Valuation: Laboratorio Farmaceutico Erfo S.p.A.

Chart: Laboratorio Farmaceutico Erfo S.p.A.

Latest news: Laboratorio Farmaceutico Erfo S.p.A.

Press Releases: Laboratorio Farmaceutico Erfo S.p.A.

News in other languages: Laboratorio Farmaceutico Erfo S.p.A.

Quotes and Performance

Price Extremes

Managers and Directors: Laboratorio Farmaceutico Erfo S.p.A.

Latest insider transactions

Other Pharmaceuticals

Financials

Company Profile

Quotes

Annual profits - Rate of surprise

04-09	Laboratorio Farmaceutico Erfo S p A : Investor Presentation Erfo SpA FY2025 (ENG)	PU
25-10-21	Laboratorio Farmaceutico Erfo S p A : 2025 10 20-ERFO-NextGEMS	PU
25-08-29	Laboratorio Farmaceutico Erfo S p A : 2025 08 28 ERFO - Press release KPI 1H 2025	PU
25-06-04	Laboratorio Farmaceutico Erfo S p A : KT Erfo 1Q25 Final	PU
25-05-19	Laboratorio Farmaceutico Erfo S p A : KT Erfo FY24 Final	PU

08-31	Milano maglia rosa in avvio; sul MIB guidano le oil
08-31	Futures deboli; Brent su dopo attacchi USA-Iran
08-28	Buy in tutta Europa, Lottomatica fa all-in sul MIB
08-28	Europee di slancio al giro di boa; MIB a 52.700
08-27	Laboratorio Farmaceutico Erfo archivia semestre con ricavi su del 2%

1 day	-0.46%
1 week	-1.81%
Current month	-5.65%
1 month	-4.82%
3 months	-4.82%
6 months	-3.12%
Current year	-26.19%

1 week	1.07	1.11
1 month	1.07	1.18
Current year	1.01	1.6
1 year	1.01	1.8
3 years	0.88	1.8
5 years	0.88	3.3
10 years	0.88	3.3

Manager	Title	Age	Since
Alessandro Cutè CEO	Chief Executive Officer	56	2012-12-31
Daniele Travisano DFI	Director of Finance/CFO	-	-

Director	Title	Age	Since
Alessandro Cutè CHM	Chairman	56	2012-12-31
Flavio Corpina BRD	Director/Board Member	47	2016-12-31
Fabio Giuffre BRD	Director/Board Member	45	-

Date	Insider	Type	Main position	Quantity	% Market Cap.
12/16/25	Alessandro Cutè	Sell	Chief Executive Officer	968,000	10.7556%
12/16/25	Alessandro Cutè	Sell	Chief Executive Officer	322,000	3.5778%
6/29/22	Alessandro Cutè	Others	Chief Executive Officer	300,000	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LABORATORIO FARMACEUTICO ERFO S.P.A.	-0.46%	-1.81%	-26.19%	-8.82%	10.63M
ELI LILLY AND COMPANY	-1.84%	+1.05%	+53.92%	+108.18%	1,043B
JOHNSON & JOHNSON	-0.54%	+0.30%	+51.82%	+67.28%	649B
ABBVIE INC.	-0.10%	+0.89%	+18.97%	+71.25%	469B
ROCHE HOLDING AG	-0.25%	+0.19%	+36.95%	+45.54%	355B
NOVARTIS AG	+0.98%	+2.91%	+20.59%	+27.14%	270B
ASTRAZENECA PLC	-1.91%	+2.42%	+10.41%	+11.04%	262B
AMGEN INC.	-0.89%	+8.00%	+41.71%	+52.30%	222B
GILEAD SCIENCES, INC.	-1.42%	+1.93%	+31.58%	+101.16%	189B
NOVO NORDISK A/S	-2.53%	-7.47%	-32.63%	-60.41%	175B
Average	-0.83%	+1.84%	+20.71%	+41.47%	363.3B
Weighted average by Cap.	-0.93%	+2.19%	+35.69%	+65.07%

	2024	2025
Net sales	6.03M 6.87M 5.67M 5.18M 9.69M 658M 9.76M 68.11M 26.4M 336M 25.81M 25.24M 1.09B	9.73M 11.09M 9.15M 8.36M 15.63M 1.06B 15.74M 110M 42.6M 541M 41.64M 40.72M 1.76B
Net income	353K 402K 332K 303K 567K 38.51M 571K 3.98M 1.54M 19.63M 1.51M 1.48M 63.65M	737K 840K 693K 633K 1.18M 80.43M 1.19M 8.32M 3.23M 41.01M 3.15M 3.08M 133M
Net Debt	5.77K 6.57K 5.42K 4.96K 9.26K 629K 9.33K 65.11K 25.24K 321K 24.67K 24.13K 1.04M	295K 337K 278K 254K 474K 32.24M 478K 3.34M 1.29M 16.44M 1.26M 1.24M 53.3M